If you, your partner, or anyone else in the family has Pompe disease, you may wonder whether the disorder…
Mary Chapman
Mary graduated from Wayne State University with a degree in journalism. She began her career at United Press International, then spent a decade reporting for the Bureau of National Affairs, Inc. (now Bloomberg Industry Group). Mary has written extensively for The New York Times, and her work has appeared in publications such as Time, Newsweek, Fortune, and the Chicago Tribune. She’s won a Society of Professional Journalists award for outstanding reporting.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Mary Chapman
The Rare Diseases Clinical Research Network (RDCRN) has opened an online survey to better understand how the…
The Pompe Disease Registry and How It Can Help Your Child
If your child has Pompe disease, you may consider enrolling them in the ongoing…
What to Expect from Physiotherapy When You Have Pompe Disease
People who have Pompe disease likely will need an array of healthcare specialists to help them manage symptoms…
What’s an IEP, and How Can It Help Children with Pompe Disease?
Children with Pompe disease, like other children with special needs, may benefit from an individualized education plan…
The National Organization for Rare Disorders (NORD) has opened a financial assistance program for people in rare disease community…
Axovant Gene Therapies is collaborating with Invitae to offer free genetic testing in the United States and Canada…
Beginning on Feb. 29, Rare Disease Day, chapters from notable scientific books and clinical review articles covering rare disorders will…
An abundance of events are afoot around the world to mark Rare Disease Day 2020 on Feb. 29. The…
AskBio Launches AskFirst Advocacy Program to Educate and Support Gene Therapy Trial Participants
Asklepios Biopharmaceutical (AskBio) has introduced a collaborative program designed to educate patients who may benefit from gene therapy,…